Research analysts at William Blair lowered their Q2 2026 earnings estimates for J.Jill in a report released on Thursday, ...

Stock analysts at William Blair issued their FY2026 earnings per share estimates for shares of LENZ Therapeutics in a ...

Fintel reports that on March 21, 2025, William Blair downgraded their outlook for Valmont Industries (NYSE:VMI) from ...

Fintel reports that on March 20, 2025, William Blair downgraded their outlook for Beacon Roofing Supply (NasdaqGS:BECN) from ...

Emerging markets present a landscape of opportunity for equity investors despite macroeconomic headwinds. Click to read.

As Klarna wins installment lending for the retail giant's OnePay app, rival Affirm seeks to downplay the loss.

We recently published a list of Top 9 AI News Updates Investors Probably Missed. In this article, we are going to take a look ...

Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

Truist Financial analyst Keith Hughes maintained a Hold rating on Beacon Roofing Supply (BECN – Research Report) today. The company’s shares ...

We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...

William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The main contributor to the rating is the stability of the management team. Specifically, the fund has not seen a ...